Underrepresented populations have been historically excluded from clinical trials including women, racial and ethnic minority groups, and pregnant, lactating, pediatric and geriatric populations. While the importance of including ...
Jun 26, 2024
0
0
NIAID research has led to the availability of a new over-the-counter topical eczema probiotic. The probiotic is based on the discovery by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part ...
Jun 26, 2024
0
6
As industrialization and urbanization accelerate, noise-induced hearing loss (NIHL) has become an increasingly prevalent sensorineural hearing disorder. Despite the widespread use of hearing aids and cochlear implants to ...
Jun 25, 2024
0
1
Falls are the most common cause of injury among adults 65 and older in the United States. According to the U.S. Centers for Disease Control and Prevention, every year, more than 14 million older adults (one in four) report ...
Jun 25, 2024
0
1
In a new article, researchers at the University of Illinois Chicago debunk four common myths about the safety of intermittent fasting.
Jun 24, 2024
0
2
An unexpectedly versatile and regenerative stem cell in early embryos may be key to creating new effective fertility treatments, suggests a new study in mice from the University of Copenhagen.
Jun 24, 2024
0
9
Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring "youthful" levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms ...
Jun 21, 2024
0
48
Nine researchers from around the world have published a summary of the most recent progress in diagnosing and treating cluster headaches, as well as understanding the development of the disease. The review article was recently ...
Jun 21, 2024
0
1
Adding CD28 costimulation to cord blood-derived chimeric antigen receptor (CAR) natural killer (NK) cells targeting CD70+ cancers significantly enhanced antitumor efficacy and long-term cytotoxicity of the CAR NK cells, according ...
Jun 20, 2024
0
1
An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and ...
Jun 18, 2024
0
1
